Apathy and associated factors in Mexican patients with Parkinson's disease

Neurological Sciences

Volumn 35, Issue 5, 2014, Pages 729-734

  Rodríguez Violante, Mayela ^a   González Latapi, Paulina ^a   Cervantes Arriaga, Amin ^a   Martínez Ramírez, Daniel ^a   Velázquez Osuna, Salvador ^a   Camacho Ordoñez, Azyadeh ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Apathy; Apathy Scale; Body mass index; Dopamine agonist; Parkinson's disease

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; BIPERIDEN; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; RASAGILINE; ROTIGOTINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; INDAN DERIVATIVE;

ADULT; AGED; AGING; APATHY; APATHY SCALE; ARTICLE; BEHAVIOR DISORDER; BODY MASS; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; NEUROLOGIC DISEASE; ONSET AGE; PARKINSON DISEASE; PREVALENCE; PSYCHOLOGICAL RATING SCALE; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; CROSS-SECTIONAL STUDY; MIDDLE AGED; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

AGE OF ONSET; ANTIPARKINSON AGENTS; APATHY; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DOPAMINE AGONISTS; FEMALE; HUMANS; INDANS; MALE; MEXICO; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 84901369007     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1591-6     Document Type: Article

References (34)

1. Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL (1999) Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 67:492-496 (Pubitemid 29438205)
2. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008) Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 23:2004-2014
3. Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243-254
4. Marin RS (1990) Differential diagnosis and classification of apathy. Am J Psychiatry 147:22-30
5. Pedersen KF, Alves G, Aarsland D, Larsen JP (2009) Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 80:1279-1282
6. Serrano-Dueñas MM-MP, Merchan T, Bravo R, Serrano M (2013) Properties of the Apathy Scale (AS) for use on Parkinson's patients. Adv Parkinson's Dis 2:53-57
7. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
8. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649-2653
9. Hoehn MM (1987) Parkinson's disease: progression and mortality. Adv Neurol 45:457-461
10. Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2013) Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol 260:228-236
11. Oh JY, Kim YS, Choi BH, Sohn EH, Lee AY (2009) Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD). Arch Gerontol Geriatr 49:351-354
12. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology 40:1529-1534 (Pubitemid 20351344)
13. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695-699 (Pubitemid 41623495)
14. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 4:134-139
15. Volicer L, Frijters DH, van der Steen JT (2013) Apathy and weight loss in nursing home residents: longitudinal study. J Am Med Dir Assoc 14:417-420
16. Pedersen KF, Larsen JP, Alves G, Aarsland D (2009) Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord 15:295-299
17. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B (2002) Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 40:2257-2267 (Pubitemid 35303365)
18. Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ (2009) The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. Clin Ther 31:89-98
19. Skorvanek M, Rosenberger J, Gdovinova Z, Nagyova I, Saeedian RG, Groothoff JW, Dijk JP (2013) Apathy in elderly nondemented patients with Parkinson's disease: clinical determinants and relationship to quality of life. J Geriatr Psychiatry Neurol 26:237-243
20. Le Jeune F, Drapier D, Bourguignon A, Peron J, Mesbah H, Drapier S, Sauleau P, Haegelen C, Travers D, Garin E, Malbert CH, Millet B, Verin M (2009) Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 73:1746-1751
21. Czernecki V, Schupbach M, Yaici S, Levy R, Bardinet E, Yelnik J, Dubois B, Agid Y (2008) Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 23:964-969
22. Ray Chaudhuri K, Martinez-Martin P, Antonini A, Brown RG, Friedman JH, Onofrj M, Surmann E, Ghys L, Trenkwalder C (2013) Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER. Parkinsonism Relat Disord 19:660-665
23. Fernandez HH, Chen JJ (2007) Monoamine oxidase-B inhibition in the treatment of Parkinson's disease. Pharmacotherapy 27:174S-185S (Pubitemid 350234307)
24. Isella V, Melzi P, Grimaldi M, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I (2002) Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord 17:366-371 (Pubitemid 36041307)
25. Zgaljardic DJ, Borod JC, Foldi NS, Rocco M, Mattis PJ, Gordon MF, Feigin AS, Eidelberg D (2007) Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol 20:184-192 (Pubitemid 350195186)
26. Cubo E, Benito-Leon J, Coronell C, Armesto D (2012) Clinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study. Neuroepidemiology 38:48-55
27. Starkstein SE (2012) Apathy in Parkinson's disease: diagnostic and etiological dilemmas. Mov Disord 27:174-178
28. Kirsch-Darrow L, Marsiske M, Okun MS, Bauer R, Bowers D (2011) Apathy and depression: separate factors in Parkinson's disease. J Int Neuropsychol Soc 17:1058-1066
29. Robert G, Le Jeune F, Lozachmeur C, Drapier S, Dondaine T, Peron J, Travers D, Sauleau P, Millet B, Verin M, Drapier D (2012) Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology 79:1155-1160
30. Zahodne LB, Bernal-Pacheco O, Bowers D, Ward H, Oyama G, Limotai N, Velez-Lago F, Rodriguez RL, Malaty I, McFarland NR, Okun MS (2012) Are selective serotonin reuptake inhibitors associated with greater apathy in Parkinson's disease? J Neuropsychiatry Clin Neurosci 24:326-330
31. Sansone RA, Sansone LA (2010) SSRI-induced indifference. Psychiatry (Edgmont) 7:14-18
32. Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease. Mov Disord 27:79-83
33. Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2013) Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol. doi:10.111/ene.12165
34. Harris E, McNamara P, Durso R (2013) Apathy in patients with Parkinson disease as a function of side of onset. J Geriatr Psychiatry Neurol 26:95-104